Unknown

Dataset Information

0

The EMPEROR-Reduced trial: SGLT2 inhibitors for heart failure get more support.

ABSTRACT:

SUBMITTER: Wagdy K 

PROVIDER: S-EPMC7868098 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The EMPEROR-Reduced trial: SGLT2 inhibitors for heart failure get more support.

Wagdy Kerolos K  

Global cardiology science & practice 20201231 3

Similar Datasets

Unknown SGLT2 inhibitors and left atrial function in heart failure with reduced or mildly reduced ejection fraction.
| S-EPMC12619516 | biostudies-literature
Unknown Intravenous iron and SGLT2 inhibitors in iron-deficient patients with heart failure and reduced ejection fraction.
| S-EPMC11287326 | biostudies-literature
Unknown Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.
| S-EPMC9492270 | biostudies-literature
Unknown Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial.
| S-EPMC8014525 | biostudies-literature
Unknown Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.
| S-EPMC7834905 | biostudies-literature
Unknown Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial.
| S-EPMC8599073 | biostudies-literature
Unknown Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced.
| S-EPMC10098519 | biostudies-literature
Unknown Combined effects of ARNI and SGLT2 inhibitors in diabetic patients with heart failure with reduced ejection fraction.
| S-EPMC8595580 | biostudies-literature
Unknown Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial.
| S-EPMC8599078 | biostudies-literature
Unknown Heart failure outcomes and empagliflozin effects in patients with heart failure and reduced ejection fraction in sinus rhythm or atrial fibrillation: Data from EMPEROR-Reduced.
| S-EPMC12765366 | biostudies-literature